KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Payables (2018 - 2025)

ClearPoint Neuro's Payables history spans 13 years, with the latest figure at $723000.0 for Q3 2025.

  • For Q3 2025, Payables fell 24.29% year-over-year to $723000.0; the TTM value through Sep 2025 reached $723000.0, down 24.29%, while the annual FY2024 figure was $1.3 million, 240.97% up from the prior year.
  • Payables for Q3 2025 was $723000.0 at ClearPoint Neuro, down from $1.5 million in the prior quarter.
  • Across five years, Payables topped out at $10.8 million in Q1 2024 and bottomed at $272000.0 in Q4 2022.
  • The 5-year median for Payables is $1.2 million (2025), against an average of $2.0 million.
  • The largest annual shift saw Payables surged 748.47% in 2024 before it tumbled 88.75% in 2025.
  • A 5-year view of Payables shows it stood at $427000.0 in 2021, then crashed by 36.3% to $272000.0 in 2022, then surged by 44.49% to $393000.0 in 2023, then skyrocketed by 240.97% to $1.3 million in 2024, then crashed by 46.04% to $723000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Payables are $723000.0 (Q3 2025), $1.5 million (Q2 2025), and $1.2 million (Q1 2025).